Additional Listing

Summary by AI BETAClose X

Genus PLC announced an application for the admission of 500,000 new ordinary shares, each with a nominal value of 10p, to the Financial Conduct Authority and the London Stock Exchange. These shares will be allotted to the Company's Employee Benefit Trust to satisfy share awards under shareholder-approved share plans. Admission to the Official List and trading on the London Stock Exchange is expected to occur on September 12, 2025. These new shares will rank equally with the company's existing ordinary shares.

Disclaimer*

Genus PLC
08 September 2025
 

8 September 2025

 

Genus plc

 

Application for Additional Listing

 

Genus plc (LSE: GNS) today announces that an application has been made to the Financial Conduct Authority and the London Stock Exchange for the admission of 500,000 new ordinary shares of 10p each ('Ordinary Shares') in Genus, which will be allotted to the Company's Employee Benefit Trust to be used to satisfy share awards under Genus plc's shareholder-approved share plans.

It is expected that the 500,000 Ordinary Shares will be admitted to the Official List and to trading on the London Stock Exchange on 12 September 2025. The shares will rank pari passu with the existing Ordinary Shares of the Company.

 

For further information please contact:

 

Genus:

Vaughn Walton, Deputy Company Secretary                                      

Tel: +44 (0)1256 347100

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Genus (GNS)
UK 100

Latest directors dealings